(Q51571255)

English

Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo.

scientific article published in March 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

1 reference

based on heuristic

inferred from title

essential hypertension

1 reference

based on heuristic

inferred from title

Sverre E. Kjeldsen

5

object named as

Kjeldsen SE

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

author name string

Seljeflot I

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Moan A

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Aspelin T

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Tønnessen T

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Arnesen H

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

47

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

292-296

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Plasma immunoreactive endothelin in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Endothelin: potential role in hypertension and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Plasma endothelin levels in hypertension and chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Plasma immunoreactive endothelin-1 in experimental malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Potential role of endothelin in hypertension. Controversy on endothelin in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Cellular mechanism of endothelin-1 release by angiotensin and vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Elevated plasma endothelin in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Increased plasma levels of endothelin in diabetic patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Pressure enhances endothelin-1 release from cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Relationship between hemorrheologic factors and insulin sensitivity in healthy young men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Insulin modulates circulating endothelin-1 levels in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Endothelin-1 decreases glucose, inhibits glucagon, and stimulates insulin release in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Nitric oxide release accounts for insulin's vascular effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990259-1

7 January 2021

Identifiers

10.1016/S0026-0495(98)90259-1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/9500565

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51571255&oldid=2078889551"